| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |